E50 (Etoposide 50 mg)
Pill with imprint E50 is Pink, Capsule-shape and has been identified as Etoposide 50 mg. It is supplied by Mylan Pharmaceuticals Inc..
Etoposide is used in the treatment of small cell lung cancer; cancer; hodgkin's lymphoma; ovarian cancer; testicular cancer and belongs to the drug class mitotic inhibitors. There is positive evidence of human fetal risk during pregnancy. Etoposide 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for E50
Etoposide
- Imprint:
- E50
- Strength:
- 50 mg
- Color:
- Pink
- Size:
- 23.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Mitotic inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- citric acid anhydrous
gelatin
glycerin
hypromellose
ferric oxide red
polyethylene glycol
propylene glycol
water
ferrosoferric oxide
titanium dioxide
Note: Inactive ingredients may vary.
More about etoposide
- Etoposide Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- Drug class: mitotic inhibitors
Consumer resources
- Etoposide
- Etoposide injection
- Etoposide phosphate
- Etoposide Capsules
- Etoposide (Advanced Reading)
- Etoposide Oral, Intravenous (Advanced Reading)
Other brands: VePesid, Toposar, Etopophos
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
